ADVISORY COMMITTEE

Head of the Laboratory of Membrane and Liposome Research at the Department of Biochemistry of the Hebrew University–Hadassah Medical School, Jerusalem, Israel. Professor Barenholz has 46 years experience in development R&D – Executive Editor of Progress in Lipid Research and the author of over 350 publications,  co-inventor of over 30 patent families, two of which underlie Doxil® for the treatment of breast and ovarian cancer (a doxorubicin remote-loaded sterically-stabilized ~100 nm liposome for treatment of cancer marketed by Johnson & Johnson). Granted various awards for outstanding contributions to the field of liposome science. A renowned specialist in biochemistry, biophysics, nanotechnology, and cancer. Received B.Sc., M.Sc. (cum laude) and Ph.D. degrees, all in Biochemistry, from the Hebrew University of Jerusalem, Israel.

Dr. Pergolizzi has extensive academic, clinical, and business achievements related to his lifelong interest in advancing medical science and the practice of modern global healthcare.  He has gained a strong reputation as an experienced, results-oriented C-level leader with a particular focus on new companies.  He has held various C-level positions in private and public companies.  He can leverage his significant medical expertise, regulatory experience, and business skills to build a strong track record of success in many fields in the healthcare industry.  Dr. Pergolizzi is a Senior Partner at Naples Anesthesia and Pain Associates and serves as the Chief Operating Officer at NEMA Research Inc. He is a former subcommittee member of the FDA SUI and SGE VAH Grant Review for Analgesics and a Consultant to the National Pain Foundation Board of Directors.

Global Head of R&D at Novartis Animal Health and VP R&D at Pfizer Animal Health. Former senior executive at Merial and Merck.

Extensive global experience in the pharmaceutical industry. Managerial positions at Teva Pharmaceutical for more than 20 years, as CEO Israel & Africa, VP Commercial International group, VP Russia and Eastern Europe countries.